Viloxazine for children and teens with ADHD
Part of Mental health clinical trials.
This study tests a new non-stimulant medication called viloxazine for children and teens with ADHD. It aims to see if it helps reduce symptoms like inattention and hyperactivity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 6 and 17 years old
- Have a diagnosis of attention-deficit/hyperactivity disorder (ADHD)
- Meet a certain weight, depending on age
- Have not taken certain medications recently (or be willing to stop current ADHD meds before the study)
- Be free of certain serious health conditions
- For females who have started their period, agree to use birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether viloxazine extended-release can reduce ADHD symptoms in children ages 4–5. It also checks safety in preschool-age kids, including heart and nervous-system side effects.
This study tests a long-acting form of the medicine clonidine (called Onyda XR) to see if it safely reduces symptoms of ADHD and oppositional defiant disorder in children. Children who join will take the study medicine or a placebo for a set period, and their symptoms will be tracked.
This study tests a new device and algorithm that may help diagnose ADHD in children and teens. It compares results from kids already diagnosed with ADHD to those without, using a wearable monitor and performance tests.
This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.
This trial tests whether omega-3 fatty acids can improve attention and hyperactivity in people with ADHD. It compares omega-3 treatment against a placebo to see if it helps reduce symptoms.
This study tests a medication called Foquest to see if it helps older adults with ADHD. It aims to improve attention and reduce hyperactivity or impulsivity in people aged 65 and above.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.